2012 annual financial data
Anixa Biosciences 2012 Operating cash flow margin
Direct answer
Operating cash flow margin was -334.12%.
Operating income was -4,134,556 USD and net income was -4,252,799 USD.
Operating cash flow was -3,140,748 USD.
Get free Anixa Biosciences email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 940,010 USD
- Operating income
- -4,134,556 USD
- Net income
- -4,252,799 USD
- Operating cash flow
- -3,140,748 USD